RxDoctor Payments Data

Pinkus Goldberg

Allergy & Immunology · Indianapolis, INNPI 1740262641

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (43.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Sanofi-aventis U.S. LLC at 42.9% of the total. Reporting peaked in 2019 at $80,680 and has fallen 98.8% since, to $953 in 2025.

$89,092in general payments, 2019–2025

Across 146 payments — averaging $610.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi-aventis U.S. LLC$38K
  • Shire North American Group Inc$19K
  • Genentech USA, Inc.$15K
  • Boehringer Ingelheim$8K
  • Takeda Pharmaceuticals U.S.A., Inc.$4K
  • AstraZeneca$976
  • plus $4K from 16 others

What the payments were for

  • Consulting fees$38,31743%
  • Speaking & faculty fees$38,94744%
  • Travel & lodging$4,9116%
  • Food & beverage$6,8188%
  • Education$990%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$89,092 in reported general payments places this provider in the 85th percentile of 49 allergy & immunology providers in Indiana.

See all allergy & immunology providers in Indiana

Other allergy & immunology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →